Literature DB >> 16537600

Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon.

Tetsuro Shimakami1, Masao Honda, Takashi Kusakawa, Takayuki Murata, Kunitada Shimotohno, Shuichi Kaneko, Seishi Murakami.   

Abstract

We previously reported that nucleolin, a representative nucleolar marker, interacts with nonstructural protein 5B (NS5B) of hepatitis C virus (HCV) through two independent regions of NS5B, amino acids 208 to 214 and 500 to 506. We also showed that truncated nucleolin that harbors the NS5B-binding region inhibited the RNA-dependent RNA polymerase activity of NS5B in vitro, suggesting that nucleolin may be involved in HCV replication. To address this question, we focused on NS5B amino acids 208 to 214. We constructed one alanine-substituted clustered mutant (CM) replicon, in which all the amino acids in this region were changed to alanine, as well as seven different point mutant (PM) replicons, each of which harbored an alanine substitution at one of the amino acids in the region. After transfection into Huh7 cells, the CM replicon and the PM replicon containing NS5B W208A could not replicate, whereas the remaining PM replicons were able to replicate. In vivo immunoprecipitation also showed that the W208 residue of NS5B was essential for its interaction with nucleolin, strongly suggesting that this interaction is essential for HCV replication. To gain further insight into the role of nucleolin in HCV replication, we utilized the small interfering RNA (siRNA) technique to investigate the knockdown effect of nucleolin on HCV replication. Cotransfection of replicon RNA and nucleolin siRNA into Huh7 cells moderately inhibited HCV replication, although suppression of nucleolin did not affect cell proliferation. Taken together, our findings strongly suggest that nucleolin is a host component that interacts with HCV NS5B and is indispensable for HCV replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537600      PMCID: PMC1440399          DOI: 10.1128/JVI.80.7.3332-3340.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Suggestions for "safe" residue substitutions in site-directed mutagenesis.

Authors:  D Bordo; P Argos
Journal:  J Mol Biol       Date:  1991-02-20       Impact factor: 5.469

2.  Hypervariable regions in the putative glycoprotein of hepatitis C virus.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; S Ohkoshi; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

3.  Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon.

Authors:  Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin.

Authors:  C F Semenkovich; R E Ostlund; M O Olson; J W Yang
Journal:  Biochemistry       Date:  1990-10-16       Impact factor: 3.162

5.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.

Authors:  I Saito; T Miyamura; A Ohbayashi; H Harada; T Katayama; S Kikuchi; Y Watanabe; S Koi; M Onji; Y Ohta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Suppression of hepatitis C virus replicon by TGF-beta.

Authors:  Takayuki Murata; Takayuki Ohshima; Masashi Yamaji; Masahiro Hosaka; Yusuke Miyanari; Makoto Hijikata; Kunitada Shimotohno
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

7.  Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins.

Authors:  A J Weiner; M J Brauer; J Rosenblatt; K H Richman; J Tung; K Crawford; F Bonino; G Saracco; Q L Choo; M Houghton
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

8.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

Authors:  A J Weiner; H M Geysen; C Christopherson; J E Hall; T J Mason; G Saracco; F Bonino; K Crawford; C D Marion; K A Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  NSR1 is required for pre-rRNA processing and for the proper maintenance of steady-state levels of ribosomal subunits.

Authors:  W C Lee; D Zabetakis; T Mélèse
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

View more
  17 in total

1.  Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.

Authors:  Corey A Balinsky; Hana Schmeisser; Sundar Ganesan; Kavita Singh; Theodore C Pierson; Kathryn C Zoon
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.

Authors:  Robert Smolic; Martina Smolic; John H Andorfer; Catherine H Wu; Robert M Smith; George Y Wu
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

3.  Nucleolin interacts with the feline calicivirus 3' untranslated region and the protease-polymerase NS6 and NS7 proteins, playing a role in virus replication.

Authors:  Clotilde Cancio-Lonches; Martha Yocupicio-Monroy; Carlos Sandoval-Jaime; Iván Galvan-Mendoza; Luis Ureña; Surender Vashist; Ian Goodfellow; Juan Salas-Benito; Ana Lorena Gutiérrez-Escolano
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.

Authors:  Yuki Nishimura-Sakurai; Naoya Sakamoto; Kaoru Mogushi; Satoshi Nagaie; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka-Fujita; Yuko Onuki-Karakama; Goki Suda; Kako Mishima; Machi Yamamoto; Mayumi Ueyama; Yusuke Funaoka; Takako Watanabe; Seishin Azuma; Yuko Sekine-Osajima; Sei Kakinuma; Kiichiro Tsuchiya; Nobuyuki Enomoto; Hiroshi Tanaka; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-12-12       Impact factor: 7.527

5.  Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids.

Authors:  Ken Sagou; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

6.  Baculovirus mediated production of infectious hepatitis C virus in human hepatoma cells stably expressing T7 RNA polymerase.

Authors:  Xiangjie Yao; Qingxia Han; Jianhua Song; Changyong Liang; Takaji Wakita; Rongge Yang; Xinwen Chen
Journal:  Mol Biotechnol       Date:  2008-06-10       Impact factor: 2.695

Review 7.  Hepatitis C virus proteins.

Authors:  Jean Dubuisson
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

8.  Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP).

Authors:  Yaohui Wang; Yuchan Wang; Yan Xu; Wenyan Tong; Tingting Pan; Jianhua Li; Shuhui Sun; Junjie Shao; Huanping Ding; Tetsuya Toyoda; Zhenghong Yuan
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

9.  The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells.

Authors:  Asako Murayama; Tomoko Date; Kenichi Morikawa; Daisuke Akazawa; Michiko Miyamoto; Minako Kaga; Koji Ishii; Tetsuro Suzuki; Takanobu Kato; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  Affinity Purification of the Hepatitis C Virus Replicase Identifies Valosin-Containing Protein, a Member of the ATPases Associated with Diverse Cellular Activities Family, as an Active Virus Replication Modulator.

Authors:  Zhigang Yi; Caiyun Fang; Jingyi Zou; Jun Xu; Wuhui Song; Xiaoting Du; Tingting Pan; Haojie Lu; Zhenghong Yuan
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.